Rosenheck, Robert <br/><br/>
Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.  [electronic resource] 

 -  JAMA  Nov 2003 
 - 2693-702 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Comparative Study; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. 
<br/><br/><label>ISSN: </label>1538-3598 
<br/><br/><label>Standard No.: </label>10.1001/jama.290.20.2693  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Akathisia, Drug-Induced<br/>Antipsychotic Agents--adverse effects<br/>Benzodiazepines<br/>Benztropine--therapeutic use<br/>Double-Blind Method<br/>Female<br/>Haloperidol--adverse effects<br/>Health Care Costs<br/>Health Services--statistics & numerical data<br/>Humans<br/>Male<br/>Middle Aged<br/>Muscarinic Antagonists--therapeutic use<br/>Neuropsychological Tests<br/>Olanzapine<br/>Pirenzepine--adverse effects<br/>Quality of Life<br/>Schizophrenia--drug therapy<br/>Treatment Outcome<br/>United States